Total raised
$12.6M
Last: Series A 2023-07
Stage
Series A
Founded
2016
Headcount
24
HQ
Or Yehuda
Sector
Health Tech & Life Sciences
About
Append Medical has developed a minimally invasive implantable device designed to reduce stroke risk in patients suffering from atrial fibrillation. The Append Medical system is designed to prevent blood clot leakage by achieving complete LAA closure thus reducing the risk of stroke in patients with non-valvular atrial fibrillation. Its unique design may allow it to mitigate device-related thromboembolism risk by leaving minimal foreign material at the closure site.
The Left Atrial Appendage exclusion technology was invented by Dr. Leonid Sternik and developed at Sheba Medical Center, further licensed by Append Medical. The company is a portfolio company of MEDX Xelerator.
Funding history · 3 rounds · $12.6M total
2023-07
Series A
$4.3M
2021-08
Series A
$7.4M
2018-06
Seed
$800K
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
medical-technologiesminimally-invasivemedical-devicescardiologystrokecardiovascularpreventionhospitals